CVR number 29214166
Industry 32.5000 Manufacture of medical and dental instruments and supplies

KLINISK TANDTEKNIKER OLE HØY ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  2.8% 3.3% 3.3% 3.4% 3.1%  
Credit score (0-100)  60 54 53 53 55  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  4,171 5,078 6,175 7,021 7,996  
EBITDA  1,523 1,534 2,198 1,975 2,183  
EBIT  1,364 1,341 1,805 1,657 1,746  
Pre-tax profit (PTP)  1,376.9 1,374.3 1,825.2 1,694.3 1,783.8  
Net earnings  1,072.0 1,071.2 1,417.4 1,319.1 1,390.0  
Pre-tax profit without non-rec. items  1,377 1,374 1,825 1,694 1,784  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  593 456 966 1,582 1,319  
Shareholders equity total  1,816 1,787 2,104 2,023 2,113  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 49.1  
Balance sheet total (assets)  3,137 3,324 3,750 3,899 3,575  
Net Debt  -1,202 -889 -905 -602 42.8  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,171 5,078 6,175 7,021 7,996  
Gross profit growth  10.8% 21.8% 21.6% 13.7% 13.9%  
Employees  0 0 0 0 9  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,137 3,324 3,750 3,899 3,575  
Balance sheet change%  4.4% 5.9% 12.8% 4.0% -8.3%  
Added value  1,523.2 1,533.6 2,198.0 2,050.3 2,182.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  50 -385 128 246 -731  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  32.7% 26.4% 29.2% 23.6% 21.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  45.0% 42.7% 51.9% 44.5% 47.8%  
ROI %  73.4% 76.4% 94.3% 82.4% 85.1%  
ROE %  57.0% 59.5% 72.9% 63.9% 67.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  57.9% 53.8% 56.1% 51.9% 59.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -78.9% -58.0% -41.2% -30.5% 2.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 2.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 9.6%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.3 2.2 2.2 1.5 2.1  
Current Ratio  2.3 2.2 2.2 1.5 2.1  
Cash and cash equivalent  1,202.4 888.8 904.8 602.5 6.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,325.0 1,500.7 1,419.3 709.9 1,130.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 243  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 243  
EBIT / employee  0 0 0 0 194  
Net earnings / employee  0 0 0 0 154